rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
1
|
pubmed:dateCreated |
2010-4-14
|
pubmed:abstractText |
To evaluate the confirmation rate of antiphospholipid antibodies (aPL), to analyze their behaviour at confirmation time, and to study the clinical value of their confirmation.
|
pubmed:language |
ita
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:issn |
0048-7449
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
62
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
51-9
|
pubmed:meshHeading |
pubmed-meshheading:20390118-Adolescent,
pubmed-meshheading:20390118-Adult,
pubmed-meshheading:20390118-Aged,
pubmed-meshheading:20390118-Aged, 80 and over,
pubmed-meshheading:20390118-Antibodies, Antiphospholipid,
pubmed-meshheading:20390118-Antiphospholipid Syndrome,
pubmed-meshheading:20390118-Cardiolipins,
pubmed-meshheading:20390118-Cohort Studies,
pubmed-meshheading:20390118-Enzyme-Linked Immunosorbent Assay,
pubmed-meshheading:20390118-Female,
pubmed-meshheading:20390118-Humans,
pubmed-meshheading:20390118-Lupus Coagulation Inhibitor,
pubmed-meshheading:20390118-Male,
pubmed-meshheading:20390118-Middle Aged,
pubmed-meshheading:20390118-Multicenter Studies as Topic,
pubmed-meshheading:20390118-Phenotype,
pubmed-meshheading:20390118-Pregnancy,
pubmed-meshheading:20390118-Pregnancy Complications,
pubmed-meshheading:20390118-Risk Factors,
pubmed-meshheading:20390118-Time Factors,
pubmed-meshheading:20390118-beta 2-Glycoprotein I
|
pubmed:articleTitle |
[Confirmation of antiphospholipid antibody positivity: a year's results in a cohort of 113 patients].
|
pubmed:affiliation |
Cattedra e U.O.C. di Reumatologia, Università di Padova, Padova, Italia. serena.cuffaro@gmail.com
|
pubmed:publicationType |
Journal Article,
Comparative Study,
English Abstract
|